Cargando…

Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis

The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the intera...

Descripción completa

Detalles Bibliográficos
Autores principales: Doelman, Ward, Marqvorsen, Mikkel H. S., Chiodo, Fabrizio, Bruijns, Sven C. M., van der Marel, Gijsbert A., van Kooyk, Yvette, van Kasteren, Sander I., Araman, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898482/
https://www.ncbi.nlm.nih.gov/pubmed/33090600
http://dx.doi.org/10.1002/chem.202004076
Descripción
Sumario:The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the interaction of Lewis‐type glycan structures in the N‐glycan of MOG with the DC‐SIGN receptor on dendritic cells (DCs). Here, we report the synthesis of an unnatural Lewis X (Le(X))‐containing Fmoc‐SPPS‐compatible asparagine building block (SPPS=solid‐phase peptide synthesis), as well as asparagine building blocks containing two Le(X)‐derived oligosaccharides: LacNAc and Fucα1‐3GlcNAc. These building blocks were used for the glycosylation of the immunodominant portion of MOG (MOG(31‐55)) and analyzed with respect to their ability to bind to DC‐SIGN in different biological setups, as well as their ability to inhibit the citrullination‐induced aggregation of MOG(31‐55). Finally, a cytokine secretion assay was carried out on human monocyte‐derived DCs, which showed the ability of the neoglycopeptide decorated with a single Le(X) to alter the balance of pro‐ and anti‐inflammatory cytokines, inducing a tolerogenic response.